Inventor

Fansheng Kong

Inventor

Beijing, CN

Overview

5→

Patents

2017–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%

C07DHeterocyclic compounds36%

A61KPreparations for medical, dental or toiletry purposes21%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%

PatentTitleYear

10,829,492Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor2020 10,561,657Pyrrolopyrimidine compound2020 9,725,439'Quinazoline derivative and preparation method therefor'2017 9,708,295'Substituted 2-aminopyridine protein kinase inhibitor'2017 9,550,781'Kinase modulating compounds, compositions containing the same and use thereof'2017

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2017–2020Patents assigned to CENTAURUS BIOPHARMA CO LTD (5)· patent assignee history

2017–2020Patents assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (5)· patent assignee history

2017–2020Patents assigned to LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (4)· patent assignee history

2017–2020Based in Beijing, CN· patent location history

2020Patents assigned to CENTAURUS BIOPHRAMA CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CENTAURUS BIOPHARMA CO LTD	5	2017–2020
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD	5	2017–2020
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD	4	2017–2020
CENTAURUS BIOPHRAMA CO LTD	1	2020

Locations

Location	Patents	Span
Beijing, CN	5	2017–2020